Generic Engineering Construction and Projects Limited
NSE: GENCON | Information Technology
Market Fundamentals
Stock Intelligence & News
Aurobindo Pharma Limited
Aurobindo Pharma Limited has informed the Exchange about completion of of transfer of Company s domestic branded generic pharmaceutical formulations products business to Auropharm Limited, a wholly owned subsidiary of the Company |SUBJECT: General Updates
Read Full Analysis →Canada Approves First Generic Wegovy: What It Means For Weight-Loss Drug Prices
The latest clearance follows two earlier milestones for Apotex.
Read Full Analysis →Lasa Supergenerics Limited
Lasa Supergenerics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |SUBJECT: Trading Window
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Generic Engineering Construction and Projects Limited
Generic Engineering Construction and Projects Limited has informed the Exchange about Closure of Trading Window |SUBJECT: Trading Window-XBRL
Read Full Analysis →Generic Engineering Construction and Projects Limited
Generic Engineering Construction and Projects Limited has informed the Exchange about Closure of Trading Window |SUBJECT: Trading Window-XBRL
Read Full Analysis →‘It feels like a medical miracle’: How did a single QR code coupon cut my $618 Walgreens prescription to $15?
“This medication was generic.”
Read Full Analysis →Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal Manchanda
India's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and consumer healthcare. While US FDA approvals for complex generics remain a challenge, innovation and contract manufacturing offer significant future profit pools. Experts anticipate biosimilars could generate substantial revenue, and despite a slow start, GLP-1 drugs show long-term promise. Sun Pharma is highlighted as a preferred domestic investment.
Read Full Analysis →Zydus, Sun Pharma, Dr Reddy's In Focus: US Cancer Drug Shortage Puts India's Pharma Stocks In Focus
According to media reports, the regulator has communicated through the Indian Drug Manufacturers' Association (IDMA) to identify companies that can immediately supply ifosfamide injection, a generic chemotherapy drug used in the treatment of several cancers, including testicular, bladder and lung cancer.
Read Full Analysis →Generic Engineering Construction and Projects Limited
Generic Engineering Construction and Projects Limited has informed the Exchange about Board Meeting to be held on 25-Jun-2026 to consider and approve the Quarterly Audited Financial results of the Company for the period ended March 2026 and Other business. |SUBJECT: Board Meeting Intimation
Read Full Analysis →Aurobindo Pharma Clears Major US Regulatory Hurdle In $250 Million Lannett Deal
The Hyderabad-based drugmaker had agreed to acquire Lannett in July 2025 for $250 million as part of its strategy to strengthen its presence in the US generics market.
Read Full Analysis →Get instant alerts when GENCON breaks news
Join investors who track Generic Engineering Construction and Projects Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for GENCON?
GENCON is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Generic Engineering Construction and Projects Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding GENCON to your custom watchlist.